Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$10.16 USD
-0.21 (-2.03%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $10.10 -0.06 (-0.59%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -1.08 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 2.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.09 |
Next Year | -3.09 |
EPS (TTM) | -7.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.23M | 0.23M | 0.90M | 17.08M |
# of Estimates | 2 | 2 | 2 | 1 |
High Estimate | 0.25M | 0.25M | 1.00M | 17.08M |
Low Estimate | 0.20M | 0.20M | 0.80M | 17.08M |
Year ago Sales | 0.12M | 0.23M | 0.83M | 0.90M |
Year over Year Growth Est. | 87.50% | -2.17% | 8.17% | 1,797.78% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.08 | -1.02 | -4.09 | -3.09 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -1.17 | -1.15 | -4.64 | NA |
High Estimate | -1.00 | -0.88 | -3.39 | -1.76 |
Low Estimate | -1.17 | -1.15 | -4.64 | -4.41 |
Year ago EPS | -1.92 | -1.56 | -6.09 | -4.09 |
Year over Year Growth Est. | 43.75% | 34.62% | 32.84% | 24.49% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.08 | -1.02 | -4.09 | -3.09 |
7 Days Ago | -1.08 | -1.02 | -4.09 | -3.09 |
30 Days Ago | -1.08 | -1.02 | -4.09 | -3.09 |
60 Days Ago | -0.90 | -0.86 | -3.80 | -2.56 |
90 Days Ago | -1.08 | -1.08 | -4.00 | -3.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.08 | -1.02 | -4.09 | -3.09 |
Zacks Consensus Estimate | -1.08 | -1.02 | -4.09 | -3.09 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -1.08 | -1.56 | -1.92 | NA |
Estimate | NA | -1.56 | -1.68 | -1.68 | NA |
Difference | NA | 0.48 | 0.12 | -0.24 | 0.12 |
Surprise | NA | 30.77% | 7.14% | -14.29% | 7.87% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more